| |
|
|
Sam Sung Pharm.Ind. (001360) |
|
|
STOCK |
|
|
| Address |
SAMSUNG PHARMACEUTICAL BLDG.,614-4,JUNGGOK 1-DONG,SEOUL |
| Home Page |
www.sspharm.co.kr
|
| Established |
1954.12. 7 |
Tel |
02-3408-4500 |
| Listed |
1975. 7. 4 |
IR |
|
| Common shares O/S |
7,589,733 |
President |
Kim,Won Gyu |
| Preferred shares O/S |
|
No.of Employees |
243(2007. 6) |
| The sales has gone down due to the cancellation of the Uwhang Choengsimhwan by the FDA in Incheon. The current net profit has turned into the black digit due to the improved non-operating account despite the sales down. The financial stability has been down and the operating cash flow remains the same resulting from the working capital shortage. |
| The lawsuit in relation to the disapproveal of Uwhang Cheongsimhwan is undergoing. However it was approved by Gyeonggi Institute of Health & Environment. The sales will go up with the entry of the pesticide and the health foods amid the new medicines launched. The profitability will be improved due to the reduced fixed costs resulting from the sales up amid the tight control of the sales and administration cost. |
|
  |
(date: 2007.06, unit : %) |
| Name |
Kim Wongyu |
Sudo Pharm.Ind. |
CNK Best |
| Portion |
25.2 |
13.1 |
13.1 |
|
 |
(unit : %) |
| Sales |
Gas Myung Soo Soln |
11.2 |
Cost |
Raw Materials |
|
| Woo Whang Chong Shim Won |
8.5 |
Labors |
|
| Others |
68.0 |
Overhead |
|
|
 |
(Unit : 100Mn.Won,Won) |
| Year |
95. 5 |
95. 7 |
02. 3 |
~03.12 |
06.11 |
| Type |
BI |
RI |
RI |
CB |
RI |
| Amount |
6.48 |
32.40 |
145.81 |
30.00 |
100.00 |
|
|
|
|
